Weimai Medical Technology (Wuxi) Co., Ltd. announced that it has raised in a round of funding on October 27, 2023. The transaction included participation from new investor, Yunnan Botanee Bio-Technology Group Co.LTD.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56.26 CNY | -4.50% | -1.66% | -17.47% |
Apr. 29 | Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 62 Yuan From 87 Yuan, Keeps at Hold | MT |
Apr. 26 | Yunnan Botanee Bio-Technology Group Co.LTD Proposes Final Dividend for 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.47% | 3.42B | |
+0.07% | 263B | |
+18.97% | 20.47B | |
0.00% | 19.13B | |
+18.70% | 12.21B | |
+29.66% | 8.48B | |
+10.58% | 5.89B | |
-7.70% | 4.31B | |
-18.08% | 3.79B | |
-4.07% | 3.59B |
- Stock Market
- Equities
- 300957 Stock
- News Yunnan Botanee Bio-Technology Group Co.LTD
- Weimai Medical Technology Co., Ltd. announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD